These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Holmes B; Brogden RN; Richards DM Drugs; 1985 Dec; 30(6):482-513. PubMed ID: 3908074 [TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials. Nix DE; DeVito JM Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572 [TBL] [Abstract][Full Text] [Related]
4. Norfloxacin: a new targeted fluoroquinolone antimicrobial agent. Wolfson JS; Hooper DC Ann Intern Med; 1988 Feb; 108(2):238-51. PubMed ID: 3277508 [TBL] [Abstract][Full Text] [Related]
5. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens. Digranes A; Dibb WL; Ostervold B Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841 [TBL] [Abstract][Full Text] [Related]
6. [Laboratory and clinical studies on norfloxacin in the pediatric field]. Toyonaga Y; Koizumi M; Imai H; Sakaguchi N; Sugita M; Fukushima Y; Yamasaki M Jpn J Antibiot; 1990 May; 43(5):808-25. PubMed ID: 2391752 [TBL] [Abstract][Full Text] [Related]
7. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients. Guimaraes MA; Noone P J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708 [TBL] [Abstract][Full Text] [Related]
8. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates. Piccolomini R; Allocati N; Catamo G Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505 [TBL] [Abstract][Full Text] [Related]
9. Norfloxacin: a quinoline antibiotic. Marble DA; Bosso JA Drug Intell Clin Pharm; 1986 Apr; 20(4):261-6. PubMed ID: 3516615 [TBL] [Abstract][Full Text] [Related]
10. [Laboratory and clinical studies on norfloxacin in pediatrics]. Sato Y; Iwata S; Akita H; Sunakawa K Jpn J Antibiot; 1990 May; 43(5):826-36. PubMed ID: 2391753 [TBL] [Abstract][Full Text] [Related]
11. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates. Qadri SM; Lee G; Brodie L Drugs Exp Clin Res; 1989; 15(8):349-53. PubMed ID: 2598776 [TBL] [Abstract][Full Text] [Related]
13. Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity. Goldstein EJ Am J Med; 1987 Jun; 82(6B):3-17. PubMed ID: 3111257 [TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Ito A; Hirai K; Inoue M; Koga H; Suzue S; Irikura T; Mitsuhashi S Antimicrob Agents Chemother; 1980 Feb; 17(2):103-8. PubMed ID: 6446258 [TBL] [Abstract][Full Text] [Related]